Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

An update on the status of anatomical sciences education in United States medical schools
Drake, Richard L. , McBride, Jennifer M. , Pawlina, Wojciech

Anatomical Sciences Education | June 3, 2014 | Volume: 7 | Issue: 4 | Pages: 321-325

10.1002/ase.1468 | PMID 24895314 Get It

Curricular changes continue at United States medical schools and directors of gross anatomy, microscopic anatomy, neuroscience/neuroanatomy, and embryology courses continue to adjust and modify their offerings. Developing and supplying data related to current trends in anatomical sciences education is important if informed decisions are going to be made in a time of curricular and course revision. Thus, a survey was sent to course directors during the 2012–2013 academic years to gather information on total course hours, lecture and laboratory hours, the type of laboratory experiences, testing and competency evaluation, and the type of curricular approach used at their institution. The data gathered were compared to information obtained from previous surveys and conclusions reached were that only small or no change was observed in total course, lecture and laboratory hours in all four courses; more gross anatomy courses were part of an integrated curriculum since the previous survey; virtual microscopy with and without microscopes was the primary laboratory activity in microscopic anatomy courses; and neuroscience/neuroanatomy and embryology courses were unchanged. Anat Sci Educ 7: 321–325. © 2014 American Association of Anatomists.
Novel ANO5 homozygous microdeletion causing myalgia and unprovoked rhabdomyolysis in an Arabic man
Lahoria, Rajat , Winder, Thomas , Lui, Jie, Al‐Owain, Mohammed, Milone, Margherita

Muscle & Nerve | June 3, 2014 | Volume: 50 | Issue: 4 | Pages: 610-613

10.1002/mus.24302 | PMID 24889862 Get It

ABSTRACTIntroduction: Recessive mutations in the anoctamin‐5 gene (ANO5) cause a spectrum of clinical phenotypes, including limb‐girdle muscular dystrophy (LGMD 2L), distal myopathy, and asymptomatic hyperCKemia. Methods: In this report we describe our clinical, electrophysiological, pathological, and molecular findings in a subject with anoctaminopathy‐5. Results: A 49‐year‐old Arabic man from a consanguineous family presented with a 5‐year history of myalgias, hyperCKemia and an episode of unprovoked rhabdomyolysis. Muscle biopsy showed mild myopathic changes and interstitial amyloid deposition. ANO5 analysis detected a novel homozygous deletion of approximately 11.9 kb encompassing exons 13–17, predicted to be pathogenic. Conclusions: Anoctaminopathy‐5 can manifest with a phenotype reminiscent of metabolic myopathy and should be considered as a potential cause of myalgia and myoglobinuria. Amyloid deposition in the muscle biopsy is helpful for the diagnosis. A novel homozygous ANO5 deletion was identified, suggesting that screening for common mutations may have low yield in non‐European subjects. Muscle Nerve 50: 610–613, 2014
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
Lenders, Jacques W.M. , Duh, Quan‐Yang , Eisenhofer, Graeme, Gimenez‐Roqueplo, Anne‐Paule , Grebe, Stefan K., Murad, M. Hassan , Eisenhofer, Graeme, Naruse, Mitsuhide , Pacák, Karel , Young, William F. , Murad, M Hassan , Gimenez-Roqueplo, Anne-Paule

The Journal of Clinical Endocrinology & Metabolism | June 3, 2014 | Volume: 99 | Issue: 6 | Pages: 1915-1942

10.1210/jc.2014-1498 | PMID 24893135 Get It

Myopericytoma of the Hypothenar Eminence: Case Report
Wagner, Eric R. , Shin, Alexander Y. , Shin, Alexander Y , Wagner, Eric R

HAND | June 3, 2014 | Volume: 10 | Issue: 2 | Pages: 349-352

10.1007/s11552-014-9655-5 | PMID 26034459 Get It

Abstract Myopericytomas belong to a benign group of tumors consisting of perivascular myopericytes or pericytes with a characteristic myoid differentiation pattern. The tumor is histologically and radiographically heterogenous, similar to superficial myofibromas. We report on a case of a myopericytoma arising in the hypothenar eminence of a 58-year-old man with a history of over 15 years of ulnar-sided and midcarpal wrist pain. Decision was made to excise the mass after it had increased in size by over 50 % over a 10-year period. Excision of the mass led to remarkable relief of his symptoms in the hypothenar as well as midcarpal regions. Consideration of this rare perivascular tumor should be included in patients with slow-growing benign appearing masses within the subcutaneous tissues of the hand.
Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history
Gangat, Naseema , Wassie, Emnet A, Finke, Christy M. , Ketterling, Rhett P. , Hanson, Curtis A. , Pardanani, Animesh , Wolanskyj, Alexandra P. , Maffioli, Margherita , Casalone, Rosario , Passamonti, Francesco , Tefferi, Ayalew , Lasho, Terra L. , Wolanskyj-Spinner, Alexandra P , Ketterling, Rhett P , Passamonti, Francesco

European Journal of Haematology | June 3, 2014 | Volume: 94 | Issue: 1 | Pages: 31-36

10.1111/ejh.12389 | PMID 24889737 Get It

AbstractBackgroundVascular events in essential thrombocythemia (ET) are associated with advanced age and thrombosis history. Recent information suggests additional effect from the presence of specific mutations.ObjectivesTo examine the influence of age and thrombosis history on the reported association between mutational status and thrombosis‐free survival in ET.Patients and MethodsAnalysis was performed using a Mayo Clinic cohort of 300 ET patients, and key findings were reanalyzed by including additional 102 Italian patients.ResultsAmong 300 Mayo patients with ET (median age 55 yr, 60% females), mutational frequencies were 53% JAK2, 32% CALR, 3% MPL, and 12% JAK2, CALR and MPL wild type. One hundred and six (35%) patients experienced arterial (n = 75) or venous (n = 43) events, before (n = 55) or after (n = 71) diagnosis. In univariate analysis, compared to JAK2‐mutated cases, JAK2, CALR and MPL wild type (HR 0.31, 95% CI 0.11–0.86), and CALR‐mutated (0.53, 95% CI 0.30–0.92) patients displayed better thrombosis‐free survival. JAK2, CALR, and MPL wild type remained significant (P = 0.03; HR 0.32, 95% CI 0.11–0.9) during multivariable analysis that included age (P = 0.01) and thrombosis history (P = 0.0006); a favorable impact from CALR mutations was of borderline significance (P = 0.1; HR 0.62, 95% CI 0.35–1.1), but became significant (P = 0.02) when multivariable analysis including thrombosis history (P = 0.02) was performed on patients younger than 60 yr of age.ConclusionsThe favorable impact of mutational status on thrombosis‐free survival in ET might be most evident for JAK2, CALR, and MPL wild type patients, whereas the favorable effect from CALR mutations might be confined to young patients.
Family History of Colorectal Cancer Is Not Associated with Colorectal Cancer Survival Regardless of Microsatellite Instability Status
Phipps, Amanda I. , Ahnen, Dennis J. , Win, Aung Ko , Jenkins, Mark A. , Lindor, Noralane M. , Gryfe, Robert, Potter, John D. , Campbell, Peter T. , Newcomb, Polly A. , Win, Aung K , Jenkins, Mark A , Potter, John D

Cancer Epidemiology, Biomarkers & Prevention | June 3, 2014 | Volume: 23 | Issue: 8 | Pages: 1700-1704

10.1158/1055-9965.epi-14-0533 | PMID 24891550 Get It

Abstract Background: Individuals with a family history of colorectal cancer in first-degree relatives have an elevated risk of developing colorectal cancer themselves, particularly colorectal cancer exhibiting high microsatellite instability (MSI-high). Given that MSI-high colorectal cancer is associated with a favorable prognosis, it is plausible that having a family history of colorectal cancer could, in turn, be favorably associated with colorectal cancer survival. Methods: This study comprised N = 4,284 incident colorectal cancer cases enrolled in the Colon Cancer Family Registry via population-based cancer registries. Using Cox proportional hazards regression, we evaluated the association between family history and both overall and disease-specific survival, accounting for MSI status and tumor site via stratified analyses and statistical adjustment. Results: There was no evidence of association between family history and overall [hazard ratio (HR), 0.92; 95% confidence interval (CI), 0.79–1.08] or disease-specific survival (HR, 1.03; 95% CI, 0.85–1.24) for all cases combined, after adjustment for MSI status or tumor site. Only for rectal cancer cases was colorectal cancer family history modestly associated with more favorable overall survival (HR, 0.75; 95% CI, 0.56–0.99). Conclusions: Although individuals with a family history of colorectal cancer were more likely to have MSI-high tumors than those with nonfamilial disease, this did not translate to a survival benefit. Impact: Overall, there is no evidence that family history of colorectal cancer is associated with colorectal cancer survival; however, specific mechanisms underlying family history may have prognostic impact and merit further study. Cancer Epidemiol Biomarkers Prev; 23(8); 1700–4. ©2014 AACR.
Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets
Czaja, Albert J.

Alimentary Pharmacology & Therapeutics | June 3, 2014 | Volume: 40 | Issue: 3 | Pages: 261-279

10.1111/apt.12825 | PMID 24890045 Get It

SummaryBackgroundChemokines contribute to the pathogenesis of autoimmune hepatitis by directing the migration and positioning of inflammatory and immune cells within the liver.AimDescribe the liver‐infiltrating effector cell populations in autoimmune hepatitis, indicate the chemokines that influence their migration, describe the role of chemokines in hepatic fibrosis and identify chemokine‐directed treatment opportunities.MethodsStudies cited in Pub Med from 1972 to 2014 for autoimmune hepatitis, chemokines in liver disease, pathogenesis of autoimmune hepatitis and chemokine therapy were selected.ResultsT helper type 17 lymphocytes expressing CXCR3 and CCR6 are attracted to the liver by the secretion of CXCL9, CXCL10 and CXCL11. These cells recruit pro‐inflammatory T helper type 1 lymphocytes expressing CXCR3 and CCR5 by secreting CXCL10. Resident natural killer T cells expressing CXCR6 migrate in response to the local secretion of CXCL16, and they modulate the inflammatory response. T helper type 2 lymphocytes expressing CCR4 are attracted by CCL17 and CCL22, and they dampen the expansion of pro‐inflammatory cells. Regulatory T cells expressing CXCR3 are attracted by the secretion of CXCL9, and they help dampen the pro‐inflammatory responses. CCL2, CCL3, CCL5, CXCL4, CXCL10 and CXCL16 promote fibrosis by activating or attracting hepatic stellate cells, and CX3CL1 may prevent fibrosis by affecting the apoptosis of monocytes.ConclusionsChemokines are requisites for mobilising, directing and positioning the effector cells in immune‐mediated liver disease. They are feasible therapeutic targets in autoimmune hepatitis, and the evaluation of monoclonal antibodies that neutralise the pro‐inflammatory ligands or designer peptides that block receptor activity are investigational opportunities.
Sport Modality Affects Bradycardia Level and Its Mechanisms of Control in Professional Athletes
Azevedo, L. , Perlingeiro, Patrícia de Sá, Hachul, Denise , Gomes‐Santos, Igor L. , Allison, Thomas G. , Negrão, Carlos Eduardo , Matos, Luciana Diniz Nagem Janot de , Brum, Patrı́cia C.

International Journal of Sports Medicine | June 2, 2014 | Volume: 35 | Issue: 11 | Pages: 954-959

10.1055/s-0033-1364024 | PMID 24886917 Get It

Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents
Daher, João Paulo Lima , Moehle, Mark S. , Hinkle, Kelly M., Melrose, Heather L. , West, Andrew B. , Cowell, Rita M. , Standaert, David G. , Volpicelli‐Daley, Laura A.

Journal of Comparative Neurology | June 2, 2014 | Volume: 522 | Issue: 11 | Pages: No page available

10.1002/cne.23612 Get It

ABSTRACTMutations in leucine‐rich repeat kinase 2 (LRRK2) are found in a significant proportion of late‐onset Parkinson's disease (PD) patients. Elucidating the neuroanatomical localization of LRRK2 will further define LRRK2 function and the molecular basis of PD. Here, we utilize recently characterized monoclonal antibodies to evaluate LRRK2 expression in rodent brain regions relevant to PD. In both mice and rats, LRRK2 is highly expressed in the cortex and striatum, particularly in pyramidal neurons of layer V and in medium spiny neurons within striosomes. Overall, rats have a more restricted distribution of LRRK2 compared with mice. Mice, but not rats, show high levels of LRRK2 expression in the substantia nigra pars compacta. Expression of the pathogenic LRRK2‐G2019S protein from mouse bacterial artificial chromosome (BAC) constructs closely mimics endogenous LRRK2 distribution in the mouse brain. However, LRRK2‐G2019S expression derived from human BAC constructs causes LRRK2 to be expressed in additional neuron subtypes in the rat such as striatal cholinergic interneurons and the substantia nigra pars compacta. The distribution of LRRK2 from human BAC constructs more closely resembles descriptions of LRRK2 in humans and nonhuman primates. Computational analyses of DNA regulatory elements in LRRK2 show a primate‐specific promoter sequence that does not exist in lower mammalian species. These noncoding regions may be involved in directing neuronal expression patterns. Together, these studies will aid in understanding the normal function of LRRK2 in the brain and will assist in model selection for future studies. J. Comp. Neurol. 522:2465–2480, 2014. © 2014 Wiley Periodicals, Inc.
microRNA‐Mediated Survivin Control of Pluripotency
Kapinas, Kristina, Kim, Heesun , Mandeville, Matthew, Martin‐Buley, Lori A., Lian, Jane B. , Wijnen, André J. van , Stein, Janet L. , Croce, Carlo Maria , Altieri, Dario C. , Stein, Gary S. , van Wijnen, Andre J

Journal of Cellular Physiology | June 2, 2014 | Volume: 230 | Issue: 1 | Pages: 63-70

10.1002/jcp.24681 | PMID 24891298 Get It

Understanding the mechanisms that sustain pluripotency in human embryonic stem cells (hESCs) is an active area of research that may prove useful in regenerative medicine and will provide fundamental information relevant to development and cancer. hESCs and cancer cells share the unique ability to proliferate indefinitely and rapidly. Because the protein survivin is uniquely overexpressed in virtually all human cancers and in hESCs, we sought to investigate its role in supporting the distinctive capabilities of these cell types. Results presented here suggest that survivin contributes to the maintenance of pluripotency and that post‐transcriptional control of survivin isoform expression is selectively regulated by microRNAs. miR‐203 has been extensively studied in human tumors, but has not been characterized in hESCs. We show that miR‐203 expression and activity is consistent with the expression and subcellular localization of survivin isoforms that in turn modulate expression of the Oct4 and Nanog transcription factors to sustain pluripotency. This study contributes to understanding of the complex regulatory mechanisms that govern whether hESCs proliferate or commit to lineages. J. Cell. Physiol. 230: 63–70, 2015. © 2014 Wiley Periodicals, Inc.